Recent studies have indicated that TRF improves insulin sensitivity and reduces body weight, blood pressure, atherogenic lipids and oxidative stress in patients with metabolic syndrome, while prevents obesity and metabolic syndrome in mice lacking a circadian clock (5, 15–17). The gene discussed is INS; the disease is metabolic syndrome.